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Previous data suggest that methylphenidate can have variable effects on different cognitive tasks both within and between individuals.
This is thought to be underpinned by inverted U-shaped relationships between cognitive performance and dopaminergic activity in
relatively separate fronto-striatal circuits and reflected by individual differences in trait impulsivity. Direct evidence for this is currently
lacking. In this study, we demonstrate for the first time that therapeutic doses of oral methylphenidate administered to young healthy
subjects result in different sized changes in D2/D3 receptor availability in different regions of the human striatum and that the change in
receptor availability within an individual subregion predicts cognitive performance on a particular task. Methylphenidate produced
significantly different effects on reversal learning and spatial working memory tasks within individuals. Performance on the reversal
learning task was predicted by the drug-induced change in D2/D3 receptor availability in postcommissural caudate, measured using
[11C]-raclopride radioligand PET imaging, whereas performance on the spatial working memory task was predicted by changes in
receptor availability in the ventral striatum.Reversal learningperformancewas also predictedby subjects’ trait impulsivity, such that the
most impulsive individuals benefitedmore frommethylphenidate, consistent with this drug’s beneficial effects on cognition in attention
deficit hyperactivity disorder.
Introduction
Psychostimulants such as the indirect catecholamine agonists
amphetamine and methylphenidate are major treatments ame-
liorating cognitive dysfunction in attention deficit hyperactivity
disorder (ADHD) (Kempton et al., 1999;Mehta et al., 2000; Aron
et al., 2003; Bedard et al., 2003). Ascending mesencephalic dopa-
mine projections to striatum and prefrontal cortex (PFC) are
implicated in working memory, cognitive flexibility, and rein-
forcement learning. The striatum’s importance in human cogni-
tion has been shownby neuropsychological (Robbins et al., 1998)
and functional neuroimaging (Vaidya et al., 1998; Cools et al.,
2004; Lewis et al., 2004; Dodds et al., 2008) studies.Methylpheni-
date’s effects on striatal dopamine are quantifiable using positron
emission tomography (PET), notably using the D2/D3 receptor
antagonist radioligand [11C]-raclopride (Volkow et al., 2001).
Drug-induced increases in extracellular dopamine reduce dopa-
mine receptor availability, resulting in a measurable reduction in
radioligand binding. Here, we used [11C]-raclopride PET to ex-
plore the relationship between different cognitive effects ofmeth-
ylphenidate and dopamine D2/D3 receptor binding within disso-
ciable striatal subregions in healthy humans.
Evidence suggests that relatively separate neocortical regions
subserve cognitive tasks such as reversal learning (Dias et al.,
1996) and spatial working memory (SWM) (Williams and
Goldman-Rakic, 1995). The distribution of these regions’ striatal
projections (Divac et al., 1967; Haber et al., 2006) makes it likely
that these tasks’ striatal substrates are also relatively distinct, al-
though diffuse connections between PFC and striatum also exist
(Haber et al., 2006). Striatal D2/D3 receptors are specifically im-
plicated in SWMand reversal learning inmonkeys (vonHuben et
al., 2006; Lee et al., 2007). In healthy humans, the D2 receptor
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agonist bromocriptine has different effects on spatial memory
and reversal learning (Mehta et al., 2001), which can be both
detrimental and beneficial in different individuals (Kimberg et
al., 1997). Such effects can be explained by different hypothesized
“inverted U”-shaped relationships between performance on dif-
ferent tasks and PFC dopamine, at the systems (Williams and
Goldman-Rakic, 1995;Mattay et al., 2003; Roberts et al., 1994) or
cellular (Vijayraghavan et al., 2007) levels. Such relationships
have been postulated in humans (Cools et al., 2001, 2007a) but
not demonstrated for the striatum.
The present study used neurocognitive measures of reversal
learning (Swainson et al., 2000) and SWM (Owen et al., 1990),
sensitive to methylphenidate challenge in healthy adults (Mehta
et al., 2000, 2001; Dodds et al., 2008), alongside PET measure-
ment of striatal dopamine receptor availability, assayed using
[11C]-raclopride displacement, reflecting drug-induced dopa-
mine release. We hypothesized that methylphenidate would
evoke [11C]-raclopride displacement in caudate, putamen, and
ventral striatum, consistent with studies using intravenous am-
phetamine (Drevets et al., 2001; Martinez et al., 2003). We pre-
dicted that changes in [11C]-raclopride binding potential (BP), a
measure of receptor availability, in distinct striatal subregions
would correlate with different cognitive effects of methylpheni-
date, consistent with the hypothesis of relatively distinct fronto-
striatal substrates for different cognitive processes. As trait im-
pulsivity moderated bromocriptine’s effect on cognition (task
switching) and striatal neural activity [measured with functional
MRI (fMRI)] (Cools et al., 2007b), we further hypothesized that
these drug effects would vary with trait impulsivity.
Materials andMethods
Subject recruitment and summary of study procedure. Ten healthy male
subjects (age 22–32 years) were recruited via public poster advertise-
ments. Exclusion criteria were previous drug use or any history of psy-
chiatric or neurological illness. Subjects underwent an initial training
session at which both of the neuropsychological tests described below
were administered. They then visited on two subsequent occasions, at
least 72 h apart, on each of which they receivedmethylphenidate (60mg,
oral; DHP Pharma) or placebo according to a double-blind, crossover
design.On each session, they also underwent [ 11C]-raclopride PET scan-
ning that commenced 60 min after capsule ingestion; immediately after
scanning, they performed the neuropsychological tests described. Blood
pressure and heart rate, and subjective affect [Positive and Negative Af-
fect Scale (PANAS)], were measured at 30 min intervals from 30 min
before drug administration, including during PET scanning. Visual an-
alog scales were used tomeasure euphoric and drug-seeking responses to
methylphenidate. Drug effects on blood pressure and visual analog scale
scores were measured as mean change from session baseline across the
period of drug effect. Trait impulsivity was measured using the self-
report Barratt Impulsiveness Scale (BIS-11) (Patton et al., 1995), which
was administered before scanning. The study was approved by the Cam-
bridge Local Research Ethics Committee and was conducted in accor-
dance with the Declaration of Helsinki.
Cognitive assessment. Cognitive effects of methylphenidate were as-
sessed with two tasks, reversal learning and spatial working memory.
Tasks were administered on a personal computer with a 10.5 inch touch
sensitive monitor, and responses on both tasks were recorded using
touch-screen control.
Reversal learning (Swainson et al., 2000).The reversal learning task was
used to assess the acquisition and flexible adaptation of a stimulus-
reinforcement association. On each trial, the subject was presented with
two stimuli, one red and one green, which appeared randomly in two of
four spatial locations on the monitor. The subject was required to select
one of the two stimuli on each trial, after which feedback was provided in
the form of the word “correct” or “incorrect” on the screen and a high or
low tone, respectively. The subject was unaware ofwhich colored boxwas
designated correct and was required to learn the stimulus–reward asso-
ciation by trial and error. The correct stimulus was arbitrarily designated
as the subject’s first response. In the initial 40 trials (stage 1, acquisition),
the designation of the correct stimulus did not change, but on a propor-
tion of trials (25%), the subject received misleading probabilistic feed-
back such that the correct response resulted in incorrect feedback and
vice versa. After 40 acquisition trials, the stimulus–outcome contingen-
cies reversed for a further 40 trials (stage 2, reversal), such that the ini-
tially reinforced stimulus now yielded negative feedback, and the initially
incorrect stimulus now yielded positive feedback. The proportion of
trials with probabilistic feedback remained the same. The subject was
required to identify when the rule reversal had occurred and change his
response pattern accordingly. The performance measure used was the
difference between the number of errors during stage 1 (acquisition) and
stage 2 (reversal), i.e., reversal errors controlling for acquisition errors.
SWM (Owen et al., 1990). The SWM task is a self-ordered search task,
taken from the Cambridge Neuropsychological Test Automated Battery.
The subject was presented with a number of boxes on the computer
screen; behind one of the boxes was hidden a token. The subject was
required to find the token by selecting boxes on the touch-sensitive
screen. Once the token had been found, it was then hidden behind a
different box. The subject was instructed that within a trial, the token
would not be hidden behind the same box twice. To carry out the task
successfully it was, therefore, necessary to remember which of the boxes
had previously been used to hide the token. This process was repeated
until the token had been hidden behind every box. The test started with
three boxes being displayed, this number increasing by one on alternate
runs until a maximum of 12 boxes were simultaneously present. The
measure of performance used was the total number of between-search
errors (i.e., errors where the subject returned to a box that had previously
yielded a token).
Image acquisition and processing. PET data were acquired in three-
dimensional (3D)mode on aGEAdvance scanner (GEMedical Systems)
for 60 min (53 time frames) after injection of [ 11C]-raclopride. In all
cases, the injected activity was such that the injected mass of [ 11C]-
raclopride represented 1 nmol/kg to keep receptor occupancy 1%
(Hume et al., 1998). A 15 min transmission scan using rotating 68Ge rod
sources was performed before injection to correct for photon attenua-
tion. Corrections for randoms, dead time, sensitivity, and scatter were
also applied to the data. Images were reconstructed using 3D-filtered
back-projection (Kinahan andRogers, 1989) into 2.34 2.34 4.25mm
voxels with a Hanning filter applied transaxially to result in an isotropic
resolution at the center of the field of view of 6.8 mm full-width at
half-maximum.
A T1-weighted spoiled gradient recalled echo scan (1 mm cubic vox-
els) was acquired for each subject on a Bruker 3TMR system to facilitate
region of interest (ROI) delineation and partial volume correction. PET
images were first realigned using the Statistical ParametricMapping soft-
ware package (SPM2; Institute ofNeurology, London,UK) to reduce any
error resulting from head motion during the PET scan. The mean re-
aligned image was then coregistered to the MR using the normalized
mutual information algorithm of SPM2. All the realigned PET images
were subsequently resliced to be coregistered with the MR.
Bilateral ROIs were drawn manually on individual subjects’ MR im-
ages using theAnalyze software package (MayoClinic). On each side, five
striatal ROIs were drawn using the method described by Mawlawi et al.
(2001) and Martinez et al. (2003) (Fig. 1). To facilitate partial volume
correction, the striatal ROIs were encompassed by an ellipsoidal back-
ground region of1.5 cm thickness. Partial volume correction was per-
formed for each resliced PET image using an implementation of the
Rousset algorithm (Rousset et al., 1998). The partial volume corrected
striatal ROI time-activity curves were used as input into an implementa-
tion of the basis function simplified reference tissue model (Gunn et al.,
1997) to determine ROI binding potential, with the cerebellum being
used as the reference tissue.
The PET metric used in the analysis was percentage BP change from
baseline (see Eq. 1). ((Placebo BPDrug BP)/Placebo BP) 100% (Eq.
1). Providing there is no change in D2/D3 receptor density or raclopride
affinity between the two PET scans, Equation 1 gives the percentage
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reduction in D2/D3 receptor availability attrib-
utable to the drug-induced increase in synaptic
dopamine level.
Data analysis. Cardiovascular and subjective
effects of methylphenidate were assessed using
paired sample t tests in Statistical Package for
the Social Sciences (version 14). Effects of
methylphenidate on raclopride binding poten-
tial were assessed using a repeated-measures
ANOVA with drug (drug vs placebo), hemi-
sphere (left vs right), and region of interest (five
levels) as within-subject factors of interest and
session order (drug first or placebo first) as a
between-subjects factor. Differences in binding
potential change (Eq. 1, averaged across hemi-
spheres) between striatal subregions were as-
sessed using post hoc tests on a further repeated-
measures ANOVA with region of interest as a
within-subjects factor and session order as a
between-subjects factor, with Bonferroni cor-
rection for multiple comparisons. Cognitive ef-
fects of methylphenidate were initially assessed
using paired sample t tests. The difference in
effect ofmethylphenidate between the two tasks
within individuals was assessed using a one-
sample t test on the size of the difference in the
Z-score of the drug effect between the tasks.
Associations between drug-induced changes in
cognitive performance measures, BP change
values from each of the five ROIs, and trait im-
pulsivity (BIS-11) were calculated using Ken-
dall’s tau-b coefficients, to minimize the influ-
ence of outliers on the small sample sizes
(Kruskal, 1958).
Results
Cardiovascular effects
of methylphenidate
Methylphenidate administration pro-
duced significant increases in systolic
blood pressure (mean paired difference,
22 mmHg; t(9) 4.1; p 0.003) and heart
rate (mean paired difference, 9.5 beats per
minute; t(9)  2.4; p  0.042) relative to
placebo.
Subjective effects of methylphenidate
Comparedwith placebo,methylphenidate significantly increased
positive affect on the PANAS (mean paired difference, 6.4; t(9)
2.9; p 0.016), with the drug minus placebo change score vary-
ing from2 to19 across subjects. Methylphenidate had posi-
tive effects on visual analog scales assessing drug liking (“like
drug” mean paired difference, 15.9; t(9)  4.3; p  0.002) and
drugwanting (“want drug now”mean paired difference, 25.6; t(9)
 2.6; p 0.029).No subject had an aversive response to the drug
(range of drug minus placebo like drug, 0–26.5; want drug now,
0–78). There was no significant effect on the negative affect sub-
scale of the PANAS (t(9)  0.76; p  0.47) or on a visual analog
rating of anxiety (t(9) 1.5; p 0.17). One individual who gave
high ratings of anxiety after drug (94.5 of 100) also displayed a
strong positive affective response to the drug (drug minus pla-
cebo PANAS positive score16).
Regional displacement of [11C]-raclopride
Analysis of one individual’s PET data from his drug session pro-
duced markedly outlying results, particularly in the ventral stria-
tum. This individual was the only one to have a substantial anx-
ious response tomethylphenidate (see above), and he was seen to
move excessively during scanning, resulting in an abnormally
shaped PET time activity curve.His PETdatawere excluded from
all analysis.
The magnitude of [ 11C]-raclopride displacement (placebo
minus drug binding potential relative to placebo) for individ-
ual regions of interest in the remaining nine subjects is sum-
marized in Figure 2. A repeated-measures ANOVA revealed
no main effect of, or interactions with, hemisphere ( p  0.2)
or session order (all p  0.1). Significant main effects were
found for the factors drug (F(1,8) 36.4; p 0.001) and region
of interest (F(4,5)  16.3; p  0.001), and importantly there
was a significant drug by region interaction (F(4,5) 10.6; p
0.001). Post hoc comparisons on the drug-induced BP change
scores, collapsed across hemisphere and corrected for multiple
comparisons, revealed greater displacement in the postcom-
missural putamen compared with precommissural putamen
[mean difference, 12.0% (95% confidence interval, 3.7–20.4);
p  0.007] and precommissural caudate [mean difference,
18.9% (0.56–37.2); p  0.043], and a trend toward greater
Figure 1. Striatal ROIs for one representative subject. The top portion of the figure shows a 3D rendering of the striatum; the
bottomportion shows a coronal T1-weightedMRI brain slice at the anterior commissure,with ROIs superimposed. Regions are (1)
ventral striatum, includingnucleus accumbens, ventral caudate, and ventral putamen (green), (2) precommissural dorsal caudate
(purple), (3) precommissural dorsal putamen (yellow), (4) postcommissural dorsal putamen (blue), and (5) postcommissural
dorsal caudate (red).
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displacement in ventral striatum than in precommissural cau-
date [mean difference, 14.3% (1.5–30.0); p  0.081].
Effects of methylphenidate on cognitive performance
Methylphenidate did not exert a significant effect on either task
across the whole group of subjects; there was no drug effect on
reversal learning errors (mean paired difference, drugminus pla-
cebo errors  0.1; t(8)  0.12; p  0.91) or SWM errors (mean
paired difference, drug minus placebo errors  1.9; t(9) 
0.30; p 0.77). However, there was a high degree of variability
in the drug effects between different individuals as well as be-
tween different tasks (Fig. 3). Taking account of this variability, a
one-sample t test on the magnitude of the difference in Z-scores
between the drug effects on the two tasks revealed that methyl-
phenidate had significantly different effects on performance of
the two tasks (mean difference, Z-score  1.30; t(8)  4.7; p 
0.002).Z-scores for the two taskswere not significantly correlated
(r2 0.07, p 0.48; tau0.24, p 0.39).
Binding potential associations with reversal learning
A significant and strong negative correlation was found between
the magnitude of the effects of methylphenidate on D2/D3 recep-
tor availability in the postcommissural caudate nucleus (relative
difference in [11C]-raclopride BP between drug and placebo
scans) and positive drug effects on reversal performance, such
that the subjects with smaller [11C]-raclopride displacements
tended to be improved by drug, whereas those with larger dis-
placements tended to be impaired by drug (r2 0.75, p 0.003;
Kendall’s tau-b  0.67, p  0.014) (Fig. 4, left). Correlations
between D2/D3 receptor availability changes and reversal perfor-
mance were not significant in any other striatal region (all tau
0.2; all p 0.4), nor across the whole striatum (tau 0.38; p
0.17).
Trait impulsivity association with cognitive performance
The effect of methylphenidate on reversal learning also varied as
a function of trait impulsivity on the BIS. A significant positive
correlation was found between BIS score and the ameliorating
effect ofmethylphenidate on reversal learning, such that themost
impulsive individuals benefited most from drug administration
(r2 0.46; Kendall’s tau-b 0.64, p 0.03) (Fig. 4,middle). The
mean BIS score was 69 (range, 60–79). A Mann–Whitney U test
on drug-induced reduction of reversal errors, with subjects split
at median on Barratt Impulsivity Score, showed a significant dif-
ference between relatively high and low impulsive subjects (Z
2.1; p 0.038).
No correlation was found between BIS score and SWM per-
formance (tau 0.21; p 0.46) or between BIS score and base-
line performance on the reversal learning (tau 0.29; p 0.35)
or SWM (tau0.04; p 0.90) tasks.
Binding potential associations with SWM
In contrast to the association between binding potential and drug
effects on reversal learning, for the spatial working memory task,
a significant positive correlation was found between the benefi-
cial effect of methylphenidate on SWM performance and the
magnitude of [11C]-raclopride displacement in the ventral stria-
tum (r2 0.44; Kendall’s tau-b 0.65; p 0.016) (Fig. 4, right).
Subjects with relatively small BP changes in this region received
less benefit frommethylphenidate than those with relatively large
BP changes. There was a trend toward a similar correlation be-
tween SWM performance and raclopride displacement in the
precommissural caudate (r2 0.22; tau 0.50; p 0.06). Cor-
relations between D2/D3 receptor availability changes and SWM
performance were not significant in other striatal regions (all
tau 0.4; all p 0.2), nor across the whole striatum (tau 0.09;
p 0.72).
Lack of relationship between positive affective and
drug-liking/wanting and other variables
The effects described could not be accounted for by positive af-
fective or drug-liking/wanting effects of methylphenidate. No
significant correlations were found between any of the measures
significantly affected by drug and either cognitive performance
measure or either ventral striatal or postcommissural caudate BP
(all p 0.05).
Discussion
We combined psychopharmacology with neurochemical PET
imaging, demonstrating for the first time that dissociable effects
of methylphenidate on different aspects of cognition are accom-
panied by changes in D2/D3 receptor availability in distinct stri-
Figure 2. Effect of methylphenidate administration on [ 11C]-raclopride binding potential
for all striatal regions of interest (see Materials and Methods). Ordinate shows the mean per-
centage difference in BP (Eq. 1) (Materials and Methods) between drug and placebo sessions.
Error bars represent 1 SE. pre-comm, Precommissural; post-comm, postcommissural.
Figure 3. Effects of methylphenidate on reversal learning and SWM. Ordinate shows the
Z-score for difference in reversal errors, placebo minus methylphenidate. Abscissa shows the
equivalent score for between-search errors in the SWM task. Note the difference in drug effects
between tasks in most subjects (top left and bottom right quadrants).
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atal subregions. Significant changes in
caudate nucleus accompanied drug-
induced changes in reversal learning,
whereas significant changes in ventral stri-
atum accompanied drug-induced changes
in spatial working memory. Receptor
availability reflects an interaction between
receptor concentration and extracellular
dopamine concentration; dopamine re-
lease after drug administration results in
radioligand displacement, measurable as
reduced binding potential. The findings
support the hypothesis that methylpheni-
date affects different cognitive tasks by
modulating distinct fronto-striatal loops
with distinct optimal dopamine levels and
provide a neurobiological account of within-subject variability in
drug effects across different cognitive tasks.
Our data extend previous observations that dopaminergic
drug effects can also be predicted from individual differences in
trait impulsivity as measured with BIS-11 (Cools et al., 2007b).
Specifically, previous research has revealed that the dopamine D2
receptor agonist bromocriptine improved a form of task switch-
ing and potentiated striatal activity in high-impulsive subjects
but not in low-impulsive subjects. Here, we extend this finding to
the catecholamine indirect agonist methylphenidate, with im-
portant implications for understanding its cognitive enhancing
effects in ADHD. Notably, methylphenidate improved reversal
learning in high-impulsive subjects to a significantly greater ex-
tent than in low-impulsive subjects.
Our data also clarify mechanisms underlying cognitive effects
of dopaminergic medications in healthy individuals, with impli-
cations for disorders including Parkinson’s disease and schizo-
phrenia, as well as ADHD. They are consistent with the hypoth-
esis that, as in prefrontal cortex (Williams and Goldman-Rakic,
1995; Arnsten and Goldman-Rakic, 1998), different striatal sec-
tors are optimally “tuned” to different levels of dopamine activity
according to the Yerkes–Dodson principle, to mediate distinct
cognitive functions.
Individual effects of methylphenidate on reversal learning
were variable. However, this variability was resolved when the
degree of raclopride displacement in the postcommissural cau-
date nucleus was taken into account. The greatest degree of raclo-
pride displacement was associated with poorer performance un-
der methylphenidate and the least displacement with superior
performance compared with placebo. This anatomical locus of
the effect of methylphenidate on reversal learning via dopamine
D2/D3 receptors is consistent with other lines of evidence. For
example, this region of the striatum has been found to be associ-
ated with reversal learning in monkeys bearing lesions of the
caudate nucleus (Divac et al., 1967). Consistent with an effect at
striatal dopamine receptors, raclopride administration in rhesus
monkeys producedmarked reversal learning impairments (Lee et
al., 2007), and in humans, L-DOPA impaired probabilistic rever-
sal learning in patients with Parkinson’s disease (Swainson et al.,
2000; Cools et al., 2001) and abolished the reversal-related blood
oxygen level-dependent (BOLD) signal in the nucleus accumbens
(Cools et al., 2007a).
Some previous studies have found an association between this
task and more ventral striatal regions. For example, a functional
imaging study using PET with H2
15O showed that reversal learn-
ing was associated with increased regional blood flow within the
ventral caudate nucleus (Rogers et al., 2000); also, a pharmaco-
logical fMRI study of reversal learning (Dodds et al., 2008)
showed that methylphenidate modulated the striatal BOLD re-
sponse associatedwith reversal learning, with the precise location
of this modulation in the ventral putamen. This variability of
localization of reversal-associated functional imaging responses
parallels variable localization of reward-related responses de-
tected with fMRI (McClure et al., 2003; O’Doherty et al., 2003;
Knutson et al., 2005), possibly reflecting the relative imprecision
of activation localization with fMRI attributable to suboptimal
normalization procedures (Brett et al., 2002). Furthermore, drug
effects on dopamine receptors may not necessarily occur in those
regions most active in a task (and therefore associated with func-
tional MRI BOLD signal change) either under control or medi-
cated conditions.
In contrast to the direction of the BP relationshipwith reversal
learning, SWMperformancewas superior to placebo at the great-
est level of raclopride displacement in ventral striatum. SWM is
often linked with dorsolateral (dl-) PFC function in humans and
might thus be expected to be related to the striatal projection
zone of the dl-PFC, the caudate nucleus. Indeed, Levy et al.
(1997) found that local cerebral glucose utilization rates were
increased in the head of the caudate nucleus of monkeys per-
forming the spatial delayed response task. This concurs with ev-
idence for increased raclopride displacement in dorsal caudate
during SWM in seven normal controls in a recent PET study
(Sawamoto et al., 2008). However, in the latter study, there was
also marginally significant raclopride displacement associated
with SWM in ventral striatum, showing that such tasks may re-
cruit more than one striatal subregion. This is compatible with
the locus of raclopride displacement in the ventral striatum (nu-
cleus accumbens) in the present study. The nucleus accumbens
has also been associated with SWM function in several animal
studies, for example in delayed alternation-type paradigms in a T
maze (Taghzouti et al., 1985) or radial maze setting (Floresco et
al., 1997). The precise aspect of working memory associated with
ventral striatal raclopride displacement is not clear: a motiva-
tional effect may be possible, although none of the subjective
mood or “liking” scales were associated with ventral striatal
raclopride displacement. This lack of effect may have derived
from using the oral rather than the intravenous route, which we
chose to simulate the likely clinical effects of methylphenidate in
ADHD.
The differential effects of methylphenidate on SWM and re-
versal learning suggest that these tasks engage different striatal
regions that are optimally modulated by different levels of dopa-
mine activity. This pattern of findings is consistent with previous
hypotheses (Swainson et al., 2000; Cools et al., 2001) concerning
Figure4. Left, Scatter plot showing an association betweendrug-induced reduction in D2 /D3 receptor availability in postcom-
missural caudate nucleus, expressed as percentage reduction in [ 11C]-raclopride binding potential (abscissa) and improvement in
reversal performance (reduced errors, ordinate).Middle, Scatter plot showing an association between impulsivity (Barratt Impul-
sivity Score, abscissa) and improvement in reversal performance (reduced errors, ordinate). Right, Scatter plot showing an asso-
ciation betweendrug-induced reduction inD2/D3 receptor availability in the ventral striatum (abscissa) and improvement in SWM
performance (reduced errors, ordinate).
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differential effects of L-DOPA on cognitive functioning in Par-
kinson’s disease. In those studies, L-DOPA improved some as-
pects of cognitive function (e.g., SWM and task-set switching)
but impaired reversal learning. Those results were explained in
terms of the gradient of dopamine loss from dorsal to ventral
striatum in Parkinson’s disease, the nucleus accumbens being
relatively spared (Kish et al., 1988). L-DOPAwas hypothesized to
produce an “over-dosing” of this region, in relation to other areas
that were depleted, implicating multiple inverted U-shaped
curves associated with distinct cognitive functions. These find-
ings, togetherwith the present data, can be interpreted in terms of
the original form of the Yerkes–Dodson relationship (Yerkes and
Dodson, 1908), which postulates that different tasks will have
different optima for performance. The data are also consistent
with evidence from monkeys (Roberts et al., 1994; Collins et al.,
1998) and rodents (Floresco et al., 1997; Chudasama and Rob-
bins, 2004; Chudasama et al., 2005) that different cognitive tasks
may be differentially modulated by central dopamine (although
most of those examples involved manipulations of dopamine in
the PFC). Together with the observation that bromocriptine has
opposite effects on spatial SWM and reversal learning in healthy
volunteers (Mehta et al., 2001), the contrasting effects of methyl-
phenidate in the present study suggest that the different sensitiv-
ity of these tasks is not simply related to differences in striatal
dopamine depletion, as occurs in Parkinson’s disease. Instead,
they may reflect modulation of distinct striatal subregions with
different optimal dopamine levels.
There were some limitations of the present study. First, we
were only able to test a relatively small sample of subjects both on
placebo andmethylphenidate. This sample size is not unusual for
PET studies and was demonstrated to be sufficiently large to re-
veal statistically robust correlations. Second, we were limited to
testing only one dose of methylphenidate in addition to placebo.
It is important to note that we replicate previous PET studies
using psychostimulants, which reported that D-amphetamine in
humans (Drevets et al., 2001; Martinez et al., 2003) and in the
baboon (Drevets et al., 1999), as well as intravenous methyl-
phenidate in humans (Udo de Haes et al., 2005), produced the
greatest overall changes in BP in ventral striatum and putamen.
Future dose–response designs will be necessary to confirm the
inverted U-shaped functions that we have postulated.
The inverted U-shaped function is also compatible with evi-
dence from studies by Volkow et al. (1999) on euphorigenic ef-
fects of intravenous methylphenidate in normal volunteers.
Those authors found that subjects with relatively lower striatal
D2/D3 receptor density asmeasured using raclopride experienced
positive effects of the drug, whereas those with relatively high
striatal binding found it aversive. This is consistent with findings
in rats that low binding of the D2/D3 radioligand [18F]-fallypride
in the nucleus accumbens was correlated with an increased pro-
pensity to self-administer cocaine (Dalley et al., 2007). The rats
with low accumbens binding were also impulsive, even before
cocaine exposure, which may relate to the findings that effects of
bromocriptine (Cools et al., 2007b) as well as those of methyl-
phenidate (present study) were dependent on baseline impulsiv-
ity measures, as measured using BIS-11. Apart from theoretical
implications of the present findings, there are some clinical im-
plications. Notably, methylphenidate can clearly exert detrimen-
tal as well as beneficial effects on cognition at the same dose in the
same individual, depending on the nature of the cognitive task.
Furthermore, beneficial effects appear to be stronger in subjects
with higher baseline impulsivity, possibly related to the generally
therapeutic effects of this compound in ADHD.
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